Search results for #cdifficile
🙍 presents to 🏥 w/severe CAP, no MRSA or Pseudomonas from 🫁 🧫 in past year, and last 🏥 admission 5 mo ago. However, 🙍 did have a 1st episode of #Cdifficile 2 mo ago, treated successfully. What empiric 💊🦠 would you start for CAP? #IDxPosts #IDTwitter #TwitteRx #MedTwitter
@SIDPharm In patients with community-acquired #Cdifficile our findings are similar. But substantial difference in risk between the different types of fluoroquinolones. Also amox-clav is riskier than we expected. ncbi.nlm.nih.gov/pmc/articles/P…
False #antibiotic #allergy tags for patients are harmful. It can result in the use of broad-spectrum antibiotics, more risk of #Cdifficile & #MRSA, extended healthcare stays/re-admissions to hospital, poorer outcomes/ treatment failures, increased cost etc. How do we combat this?
Thinking about #Cdifficile this week, doxycycline has been proposed to have protective effect against #Cdiff. Check out this recent large retrospective VAH study comparing #Cdiff rates between doxycycline and azithromycin given with ceftriaxone! sciencedirect.com/science/articl…
#Cdifficile can be devastating side effect of treating infections, but did you know that the specific antibiotic used can impact #Cdiff risk? Check out this infographic to C the diff-erence you can have when selecting antibiotics! #IDxPosts #IDTwitter #Antibiotics #TwitteRx
@SeiMc @Defensagob @SLAMVI @CoREIMC_seimc @javimembrillo @ESCMID @Tmatfor @IDSAInfo @Tmatfor nos habla del problema de la sobrepetición de pruebas de #Cdifficile. ¿Y en el contexto de un brote?
@SeiMc @Defensagob @SLAMVI @CoREIMC_seimc @javimembrillo @ESCMID Prime paso de la respuesta #microbiologia #24x7 haciendo PCR urgentes de #Cdifficile
@SeiMc @Defensagob @SLAMVI @CoREIMC_seimc @javimembrillo @ESCMID Situación actual de #cdifficile en 🇪🇺 #cursoinfecciosasgomezulla24
El turno del #tratamiento con #fidaxomicina presentado por @AlejandreOna del @HospitalManises en la mesa de #infeccion por #cdifficile
Seguimos con el #tratamiento del #cdifficile a cargo de José Luis Sánchez facultativo de #farmacia en @HospitalManises
⭐⭐BRAND NEW FMT GUIDELINES RELEASED ⭐⭐ Download the freely-accessible guidelines for safe and effective administration of #FMT for #Cdifficile infection from @jhieditor 👉 ow.ly/VPn950RegCV #HISGuidelines in collaboration with @BritSocGastro #IDTwitter
Study presented at #SHEA2024 conference assesses the link between antibiotic use and Clostridioides difficile Infection in Tennessee. #cdifficile #cdiff #antibiotics contagionlive.com/view/a-multi-y…
Chair of the #FMT working party Ben Mullish @bhmullish explains the significance of the newly published guidelines on the use of FMT as a therapy for recurrent or refractory #Cdifficile infection and other indications Read full story and download for free ow.ly/5gUe50RekBn
#AgnieszkaPiekarska precise academic presentation about #Cdifficile and #GvHD #EBMT24 @TheEBMT @TheEBMT_Trainee - Confirm Dx before starting treatment - Fidaxomicin ideal 1st choice of treatment - Be aware of CDI and GvHD association - Specific guidelines are needed
En #OFIDJournal 18829 pacientes con #Cdifficile analizan 882 con ≥2 episodios,FACTORES DE RIESGO de #recidiva desde 1er episodio: 🔄>65 años 🔄Hemodialisis 🔄Hospitalización reciente 🔄Nitrofurantoina en 12 semanas previas Ojo a estos pacientes!👀 🔗🆓academic.oup.com/ofid/article/1…
Mortality, infection recurrence, and severe disease in patients with #Clostridioidesdifficile infection were most commonly reported among those infected with the NAP1/BI/R027 strain. #CDI #CDIfficile #CDIstrains ➡️ brnw.ch/21wILOg
Find out more about the new #FMT guidelines - author @bhmullish explains the importance of FMT as a therapy for recurrent or refractory #Cdifficile infection and other indications. Free to read and download here: journalofhospitalinfection.com/article/S0195-…
Chair of the #FMT working party Ben Mullish @bhmullish explains the significance of the newly published guidelines on the use of FMT as a therapy for recurrent or refractory #Cdifficile infection and other indications Read full story and download for free ow.ly/5gUe50RekBn